BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 7853854)

  • 1. Detection of 17p loss in gastric carcinoma using polymerase chain reaction.
    Kim CJ; Kim WH; Kim CW; Lee JB; Lee CK; Kim YL
    Lab Invest; 1995 Feb; 72(2):232-6. PubMed ID: 7853854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of heterozygosity and p53 gene mutations in breast cancer.
    Deng G; Chen LC; Schott DR; Thor A; Bhargava V; Ljung BM; Chew K; Smith HS
    Cancer Res; 1994 Jan; 54(2):499-505. PubMed ID: 8275488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of heterozygosity of the retinoblastoma and p53 genes in primary cervical carcinomas with human papillomavirus infection.
    Kim JW; Lee CG; Han SM; Kim KS; Kim JO; Lee JM; Kim IK; Namkoong SE
    Gynecol Oncol; 1997 Nov; 67(2):215-21. PubMed ID: 9367711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Minimal commonly deleted regions on chromosome 7q31 in primary gastric carcinoma and its clinical significance].
    Li JT; Fu L; Xia JC; Feng BJ; Mai SJ; Yu XJ; Huang LX; Feng QS; Pan ZZ; Zhan YQ
    Ai Zheng; 2005 Nov; 24(11):1306-11. PubMed ID: 16552953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis].
    Xu XF; Tang PZ; Cheng SJ
    Ai Zheng; 2003 May; 22(5):452-7. PubMed ID: 12753701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of heterozygosity and tumor suppressor gene mutations in chondrosarcomas.
    Yamaguchi T; Toguchida J; Wadayama B; Kanoe H; Nakayama T; Ishizaki K; Ikenaga M; Kotoura Y; Sasaki MS
    Anticancer Res; 1996; 16(4A):2009-15. PubMed ID: 8712735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent loss of heterozygosity at the DCC locus in gastric cancer.
    Uchino S; Tsuda H; Noguchi M; Yokota J; Terada M; Saito T; Kobayashi M; Sugimura T; Hirohashi S
    Cancer Res; 1992 Jun; 52(11):3099-102. PubMed ID: 1591722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of heterozygosity on chromosomes 10 and 17 in clinically localized prostate carcinoma.
    Ittmann MM
    Prostate; 1996 May; 28(5):275-81. PubMed ID: 8610052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of chromosome 17p13 (p53 locus) alterations in gastric carcinoma cells by dual-color fluorescence in situ hybridization.
    Kobayashi M; Kawashima A; Mai M; Ooi A
    Am J Pathol; 1996 Nov; 149(5):1575-84. PubMed ID: 8909247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymerase chain reaction-based approaches for detection of allelic loss in the p53 tumor suppressor gene in colon neoplasms.
    Yamaguchi K; Sugano K; Fukayama N; Nakashima Y; Saotome K; Yokoyama T; Yokota T; Ohkura H
    Am J Gastroenterol; 1997 Feb; 92(2):307-12. PubMed ID: 9040212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allelic loss of chromosome 17p, mutation of the p53 gene, and microsatellite instability in right- and left-sided colorectal cancer.
    Watatani M; Yoshida T; Kuroda K; Ieda S; Yasutomi M
    Cancer; 1996 Apr; 77(8 Suppl):1688-93. PubMed ID: 8608563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poor correlation with loss of heterozygosity on chromosome 17p and p53 mutations in ovarian cancers.
    Sakamoto T; Nomura N; Mori H; Wake N
    Gynecol Oncol; 1996 Nov; 63(2):173-9. PubMed ID: 8910623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of heterozygosity and overexpression of the p53 gene in ovarian carcinoma.
    Frank TS; Bartos RE; Haefner HK; Roberts JA; Wilson MD; Hubbell GP
    Mod Pathol; 1994 Jan; 7(1):3-8. PubMed ID: 7909153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.
    Cornelis RS; van Vliet M; Vos CB; Cleton-Jansen AM; van de Vijver MJ; Peterse JL; Khan PM; Børresen AL; Cornelisse CJ; Devilee P
    Cancer Res; 1994 Aug; 54(15):4200-6. PubMed ID: 8033152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allelic loss on chromosome 17p and p53 mutations in human endometrial carcinoma of the uterus.
    Okamoto A; Sameshima Y; Yamada Y; Teshima S; Terashima Y; Terada M; Yokota J
    Cancer Res; 1991 Oct; 51(20):5632-5. PubMed ID: 1913680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 mutations in human malignant gliomas: comparison of loss of heterozygosity with mutation frequency.
    Frankel RH; Bayona W; Koslow M; Newcomb EW
    Cancer Res; 1992 Mar; 52(6):1427-33. PubMed ID: 1347252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of chromosomes 9p and 17 associated with abnormal expression of p53, p16/MTS1 and p15/MTS2 gene protein in hepatocellular carcinomas.
    Shao J; Li Y; Li H; Wu Q; Hou J; Liew C
    Chin Med J (Engl); 2000 Sep; 113(9):817-22. PubMed ID: 11776078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heterozygosity of the Rb gene correlates with pRb protein expression and associates with p53 alteration in human esophageal cancer.
    Xing EP; Yang GY; Wang LD; Shi ST; Yang CS
    Clin Cancer Res; 1999 May; 5(5):1231-40. PubMed ID: 10353761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization of microdissection and the polymerase chain reaction for the diagnosis of adrenal cortical carcinoma in fine-needle aspiration cytology.
    Abati A; Sanjuan X; Wilder A; Linehan WM; Hewitt SM; Merino MJ
    Cancer; 1999 Aug; 87(4):231-7. PubMed ID: 10455212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of 17p, mutation of the p53 gene, and overexpression of p53 protein in esophageal squamous cell carcinomas.
    Wagata T; Shibagaki I; Imamura M; Shimada Y; Toguchida J; Yandell DW; Ikenaga M; Tobe T; Ishizaki K
    Cancer Res; 1993 Feb; 53(4):846-50. PubMed ID: 8094033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.